$AKTS 3 SEC Filings

Filed On	Filing
16 Apr 2026	Form 3: Gormley Glenn, Director No securities owned
15 Jan 2026	Form 3: Eli Lilly & Co, 10% owner Holds 6,344,114 shares of Common Stock
08 Jan 2026	Form 3: Kuvalanka Kyle D., Chief Financial Officer
08 Jan 2026	Form 3: Kim Helen Susan, Director
08 Jan 2026	Form 3: Herrmann Ken, Director
08 Jan 2026	Form 3: Gadicke Ansbert, 10% owner and 2 others Holds 341,709 shares of Common Stock
08 Jan 2026	Form 3: Segal Lloyd Mitchell, Director
08 Jan 2026	Form 3: Roden Matthew, Director Holds 91,998 shares of Common Stock
08 Jan 2026	Form 3: Mpm Bioventures 2018, L.p., 10% owner and 7 others Holds 341,709 shares of Common Stock
08 Jan 2026	Form 3: Ron-Bigger Shulamit, Chief Operating Officer
08 Jan 2026	Form 3: Foley Todd, Director
08 Jan 2026	Form 3: Feldman Paul L, Chief Scientific Officer Holds 144,568 shares of Common Stock
08 Jan 2026	Form 3: Czibere Akos, Chief Medical Officer
08 Jan 2026	Form 3: Sherman Michael A., Director
08 Jan 2026	Form 3: Thistle Mary, Director
08 Jan 2026	Form 3: EcoR1 Capital, Llc, Director and 1 other
08 Jan 2026	Form 3: Vida Ventures II, Llc, 10% owner and 1 other

Comments